# Open-Label Study of ARD-0403 in Testosterone Deficient Men

> **NCT00562731** · PHASE3 · TERMINATED · sponsor: **Ardana Bioscience Ltd** · enrollment: 150 (estimated)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** ARD-0403

## Key facts

- **NCT ID:** NCT00562731
- **Lead sponsor:** Ardana Bioscience Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** Company strategic decision
- **Last updated:** 2008-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00562731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00562731, "Open-Label Study of ARD-0403 in Testosterone Deficient Men". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00562731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*